4-辛基衣康酸通过抑制巨噬细胞铁死亡和氧化应激减轻小鼠特应性皮炎皮肤炎症损伤OA
4-Octyl itaconate attenuates inflammatory skin injury in a mouse model of atopic dermatitis by inhibiting macrophage ferroptosis and oxidative stress
目的 探究特应性皮炎(AD)皮损内是否存在巨噬细胞铁死亡及其在 AD 中的作用,揭示 4-辛基衣康酸(4-OI)减轻 AD 炎症性皮肤损伤的作用和分子机制.方法 共 40 只雄性 C57BL/6 小鼠.取15 只随机分为3 组,每组5 只,空白对照组不作处理,另两组涂抹卡泊三醇(MC903)建立 AD 模型,分别于第0、7、14 天取背部皮损,观察皮损组织病理变化、皮损中 IL-4、IL-5、IL-13 mRNA 水平表达情况以及巨噬细胞浸润情况;另取10 只小鼠,随机分为 sham 假手术组和 MC903 造模组,每组5 只,sham 假手术组背部涂抹无水乙醇,MC903 造模组涂抹 MC903,连续处理14 d,比较两组小鼠皮损处氧化应激、巨噬细胞铁死亡、巨噬细胞内源性衣康酸/Nrf2 通路相关标志物(Acod1、GPX4、PTGS2、Nrf2、HO-1)水平;再取15 只小鼠,随机分为 sham 假手术组、MC903 造模组和 MC903+4-OI 给药组,每组5 只,MC903+4-OI 给药组在涂抹 MC903 的同时腹腔注射4-OI(50 mg/kg),连续处理14 d,评估4-OI 对小鼠 AD 皮损的干预效应.采用 HE 染色评估造模小鼠皮损处病理改变,采用实时荧光定量 PCR 及免疫印迹检测小鼠皮损内2 型炎症因子(IL-4、IL-5、IL-13)、铁死亡以及 GPX4、PTGS2、Nrf2、HO-1 水平,采用免疫荧光检测小鼠皮损内巨噬细胞浸润情况,采用 ELISA 检测小鼠皮损中 MDA 水平及流式细胞术检测皮损内 DCFDA+巨噬细胞反应氧化应激水平.结果 随着造模后时间延长,MC903 造模组皮损处表皮呈进行性增厚(P<0.05),2 型炎症因子IL-4、IL-5、IL-13 水平升高(P<0.01)、巨噬细胞浸润增多.与sham 假手术组相比较,铁死亡标志物 GPX4 下调且 PTGS2 异常升高(P<0.01),Acod1、Nrf2 及 HO-1 上调(P<0.01),同时出现脂质过氧化产物丙二醛(MDA)及皮损内 DCFDA+巨噬细胞增加(P<0.01).相对于 MC903 造模组,MC903+4-OI 给药组能显著改善皮损(P<0.01),减少 2 型炎症因子 IL-4、IL-5、IL-13 水平(P<0.01)、降低 MDA 及皮损内 DCFDA+巨噬细胞水平并逆转 GPX4 及 PTGS2 异常(P<0.05).结论 AD皮损中存在巨噬细胞铁死亡,4-OI 通过抑制氧化应激及巨噬细胞铁死亡减轻小鼠皮肤炎症损伤.
Objective To investigate whether macrophage ferroptosis occurs in atopic dermati-tis(AD)lesions and its role in AD,and to elucidate the mechanism by which 4-octyl itaconate(4-OI)alleviates AD inflammatory skin damage by inhibiting oxidative stress and macrophage fer-roptosis.Methods A total of 40 male C57BL/6 mice were used.Fifteen mice were randomly as-signed to 3 groups(n=5 each):the blank control group received no treatment,and the other two groups were treated with calcipotriol(MC903)to establish the AD model.Skin lesions were col-lected on days 0,7,and 14 post-modeling to observe histopathological changes,mRNA expression of IL-4,IL-5,and IL-13,and macrophage infiltration.Another 10 mice were randomly divided into sham and MC903-model groups(n=5 each).The sham group received topical ethanol,while the MC903-model group received topical MC903 for 14 consecutive days.The levels of oxi-dative stress,macrophage ferroptosis,and markers of the endogenous itaconate/Nrf2 pathway(Acod1,GPX4,PTGS2,Nrf2,and HO-1)in skin lesions were compared between the two groups.A further 15 mice were randomly divided into sham,MC903-model,and MC903+4-OI treatment groups(n=5 each).Mice in the MC903+4-OI group received intraperitoneal injection of 4-OI(50 mg/kg)concurrently with MC903 application for 14 consecutive days to evaluate the therapeutic effect of 4-OI on AD skin lesions.Histopathological changes were assessed by H&E staining.The expression levels of type 2 inflammatory cytokines(IL-4,IL-5,IL-13),ferroptosis-related markers,and GPX4,PTGS2,Nrf2,and HO-1 were detected by real-time quantitative PCR and Western blotting.Macrophage infiltration was examined by immunofluorescence.Oxida-tive stress was evaluated by ELISA for malondialdehyde(MDA)levels and by flow cytometry for DCFDA+macrophages in lesional skin.Results Over time following MC903 induction,the epi-dermis of lesional skin in the model group showed progressive thickening(P<0.05),along with elevated levels of type 2 inflammatory cytokines IL-4,IL-5,and IL-13(P<0.01)and increased macrophage infiltration.Compared with the sham group,the ferroptosis marker GPX4 was down-regulated and PTGS2 was abnormally upregulated(P<0.01),while Acod1,Nrf2,and HO-1 were upregulated(P<0.01).Concurrently,increased malondialdehyde(MDA)content and an elevated proportion of DCFDA+macrophages in lesional skin were observed(P<0.01).In con-trast,treatment with 4-OI significantly ameliorated skin lesions(P<0.01),reduced the levels of IL-4,IL-5,and IL-13(P<0.01),suppressed macrophage ROS and MDA production,and re-versed the abnormal expression of GPX4 and PTGS2(P<0.05)compared with the MC903 model group.Conclusions Macrophage ferroptosis is present in AD skin lesions,and 4-OI attenuates skin inflammatory damage by suppressing oxidative stress and macrophage ferroptosis.
邓威威;钟泽敏;张悦;罗宇榕;谢安生;王迪
南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091
特应性皮炎巨噬细胞铁死亡4-辛基衣康酸氧化应激
atopic dermatitismacrophage ferroptosis4-octyl itaconateoxidative stress
《皮肤性病诊疗学杂志》 2026 (8)
561-569,9
国家自然科学基金(82404119)
评论